SCHEDULE 13G//SEC Filing
AN2 Therapeutics, Inc. SCHEDULE 13G
Accession 0001596468-25-000022
CIK 0001596468other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:51 PM ET
Size
6.5 KB
Accession
0001596468-25-000022
Documents
Issuer
Almitas Capital LLC
CIK 0001596468
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001596468
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 7:51 PM ET
- Size
- 6.5 KB